semaglutide and female fertility Injectable shows promise for improving in women with PMOS Injectable Semaglutide Shows Early Promise

Less than 1% of the overall patients report dizziness, headache, or hyperactivity

Carrying extra weight goes beyond just affecting appearanceit can put significant strain on your heart, joints, and metabolic system

B12 supplementation is particularly relevant because GLP-1 agonists can reduce B12 absorption over time

In a recent meta-analysis of seven RCTs among infertile women with PCOS, LC significantly improved clinical pregnancy and ovulation rates [20], which is in line with the findings of the present study

The weekly rate of loss during this period dropped to roughly 1.1 lb per week, which is still meaningful but noticeably slower than the months 3 to 6 pace

Retatrutide is a new weight management drug manufactured by Eli Lilly and Company for the treatment of obesity